TY - JOUR
T1 - Generation and validation of novel anti-bovine CD163 monoclonal antibodies ABM-1A9 and ABM-2D6
AU - Shimamoto, Yoshinori
AU - Nio-Kobayashi, Junko
AU - Watarai, Hiroshi
AU - Nagano, Masashi
AU - Saito, Natsuko
AU - Takahashi, Eiki
AU - Higuchi, Hidetoshi
AU - Kobayashi, Atsushi
AU - Kimura, Takashi
AU - Kitamura, Hiroshi
N1 - Publisher Copyright:
© 2018 Elsevier B.V.
PY - 2018/4
Y1 - 2018/4
N2 - The scavenger receptor CD163 is widely used as a cell signature for alternatively active “M2” macrophages in mammals. In this study, we generated two monoclonal antibodies, ABM-1A9 and ABM-2D6, against the extracellular region of bovine CD163. Conventional Western blotting using the antibodies yielded immunoreactive bands of bovine CD163 at 130 and 150 kDa in non-reduced and reduced spleen lysates, respectively. The minimum limit of detectable concentration of both antibodies was relatively lower (5.0 ng/mL) than that of the anti-human CD163 monoclonal antibody AM–3 K (>1.0 μg/mL), which has been used previously for the detection of bovine CD163. An immunohistochemical study using formalin-fixed paraffin-embedded sections revealed that ABM-1A9 and ABM-2D6 clearly stained some Iba1+ macrophages in the lymph nodes of cattle with mastitis. Moreover, the CD163-stained macrophages were frequently observed engulfing leukocytes. ELISA using ABM-2D6 distinguished levels of circulating soluble CD163 in healthy cattle (less than 16.9 pmol/mL) and cattle with mastitis (more than 33.7 pmol/mL). These new monoclonal antibodies can be used in the diagnosis and evaluation of inflammatory disease prognosis in cattle with immunohistological analyses and blood test applications.
AB - The scavenger receptor CD163 is widely used as a cell signature for alternatively active “M2” macrophages in mammals. In this study, we generated two monoclonal antibodies, ABM-1A9 and ABM-2D6, against the extracellular region of bovine CD163. Conventional Western blotting using the antibodies yielded immunoreactive bands of bovine CD163 at 130 and 150 kDa in non-reduced and reduced spleen lysates, respectively. The minimum limit of detectable concentration of both antibodies was relatively lower (5.0 ng/mL) than that of the anti-human CD163 monoclonal antibody AM–3 K (>1.0 μg/mL), which has been used previously for the detection of bovine CD163. An immunohistochemical study using formalin-fixed paraffin-embedded sections revealed that ABM-1A9 and ABM-2D6 clearly stained some Iba1+ macrophages in the lymph nodes of cattle with mastitis. Moreover, the CD163-stained macrophages were frequently observed engulfing leukocytes. ELISA using ABM-2D6 distinguished levels of circulating soluble CD163 in healthy cattle (less than 16.9 pmol/mL) and cattle with mastitis (more than 33.7 pmol/mL). These new monoclonal antibodies can be used in the diagnosis and evaluation of inflammatory disease prognosis in cattle with immunohistological analyses and blood test applications.
UR - http://www.scopus.com/inward/record.url?scp=85042202282&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042202282&partnerID=8YFLogxK
U2 - 10.1016/j.vetimm.2018.02.004
DO - 10.1016/j.vetimm.2018.02.004
M3 - Article
C2 - 29571519
AN - SCOPUS:85042202282
SN - 0165-2427
VL - 198
SP - 6
EP - 13
JO - Veterinary Immunology and Immunopathology
JF - Veterinary Immunology and Immunopathology
ER -